Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)
Clinical trial NCT03568331 · COMPLETED
Trial details
- NCT number
- NCT03568331
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2019-12-27
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.